Audiofinaleheader.gif
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations

Drugs Targeting Immune Response To COVID-19 Show Promise

Researchers are reporting some progress in their search for drugs that tamp down the overwhelming immune reaction that can kill a patient with COVID-19.

Copyright 2021 NPR

Corrected: April 6, 2021 at 10:00 PM MDT
An earlier version of this story incorrectly said aviptadil is a monoclonal antibody. In fact, it is a synthetic peptide.
Award-winning journalist Richard Harris has reported on a wide range of topics in science, medicine and the environment since he joined NPR in 1986. In early 2014, his focus shifted from an emphasis on climate change and the environment to biomedical research.